About Cancer and Blood Institute
Clinical Trials at Cancer and Blood Institute
During the past decade, Cancer and Blood Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer and Blood Institute"
#1 collaborator was "Prologue Research International" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Cancer and Blood Institute
According to Clinical.Site data, the most researched conditions in "Cancer and Blood Institute" are
"Colorectal Cancer" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Pancreatic Cancer" (1 trials). Many other conditions were trialed in "Cancer and Blood Institute" in a lesser frequency.
Clinical Trials Intervention Types at Cancer and Blood Institute
Most popular intervention types in "Cancer and Blood Institute" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "CC-5013" (2 trials), "FOLFOX regimen" (1 trials), "fluorouracil" (1 trials), "gemcitabine" (1 trials) and "leucovorin calcium" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer and Blood Institute
The vast majority of trials in "Cancer and Blood Institute" are
3 trials for "All" genders.
Clinical Trials Status at Cancer and Blood Institute
Currently, there are NaN active trials in "Cancer and Blood Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Cancer and Blood Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer and Blood Institute, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".